Drug Profile
MOL 0275
Alternative Names: MOL 027-5Latest Information Update: 28 Nov 1997
Price :
$50
*
At a glance
- Originator Molecumetics
- Class Antivirals
- Mechanism of Action HIV envelope protein gp120 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 28 Nov 1997 Discontinued-Preclinical for HIV-1 infections in USA (Unknown route)
- 10 Oct 1995 Preclinical development for HIV-1 infections in USA (Unknown route)
- 29 Sep 1995 New profile